Welcome to our investor pages
Medical technology company Optomed is leading producer of handheld fundus cameras globally.
Key figures
Net sales 15.1 EUR, million
Gross margin 68,2 %
EBITDA -1.5 EUR, million
Equity ratio 70,0 %
Share Price
Nasdaq Helsinki Stock Exchange
Interim Report, January – September 2025
Read moreLatest releases
Investor events
Feb 10
- Feb 10, 2026
Financial Statement Bulletin for 1 January – 31 December 2025
May 6
- May 6, 2026
Interim Report for 1 January – 31 March 2026
Aug 14
- Aug 14, 2026
Half-Year Financial Report for 1 January – 30 June 2026
Nov 6
- Nov 6, 2026
Interim Report for 1 January – 30 September 2026
Nov 7
- Nov 7, 2024
Interim Report for 1 January – 30 September 2024
Aug 8
- Aug 8, 2024
Half-Year Financial Report for 1 January – 30 June 2024
Optomed as an investment
Optomed is a research and development as well as sales driven medical technology company in expansion phase.
Optomed is one of the leading players in the growing and transforming handheld fundus camera market.
Read more